Moe’s Group is a GMP-certified private-label manufacturer supporting brands with formulation and production aligned to current skincare trends. We develop custom products using emerging ingredients, including copper peptides, PDRN, and other advanced actives, while managing formulation, scale-up, and production.

As ingredient trends evolve, brands must evaluate new actives for stability, compatibility, and scalability. Moe’s Group supports this process by integrating emerging ingredients into manufacturable formulations that meet production and shelf-life requirements.

Supporting Product Development with Emerging Ingredients

Adapting to skincare trends requires more than ingredient selection. Formulations must remain stable, scalable, and compatible with packaging and distribution requirements. Moe’s Group supports end-to-end development, from ingredient selection through bulk manufacturing and filling.

Our production infrastructure supports scaling from small batches to over one million units per month, allowing brands to move from concept to commercial volumes efficiently.

We support efficient production timelines, including rapid turnaround for repeat orders. Our team focuses on formulation and manufacturing execution, with packaging options available throughout the production process.

Copper Peptides & PDRN: The New Standards in Skin Regeneration

Incorporating emerging actives requires careful formulation to maintain stability and compatibility within cosmetic systems. Ingredients such as copper peptides and PDRN are increasingly explored by brands to position their advanced skincare products.

  • Copper Peptides: Used in formulations where brands seek to position products around skin conditioning and maintenance.
  • PDRN (Polydeoxyribonucleotide): Integrated into serums and creams where brands are targeting premium or trend-driven product categories.

These ingredients require controlled formulation conditions to maintain consistency across batches and avoid degradation during production. These actives require controlled formulation and processing conditions to maintain stability during manufacturing and throughout the product lifecycle.

Emerging Ingredients: Exosomes and Stabilized Vitamin C Derivatives

New ingredient categories, such as exosome-based materials and stabilized Vitamin C derivatives, are being explored within cosmetic formulation. These ingredients are typically incorporated to support product differentiation and market positioning.

Lipid-soluble Vitamin C derivatives, such as Tetrahexyldecyl Ascorbate (THD), are used in formulations that require oxidation resistance and compatibility with oil-based systems.

Incorporating these materials requires formulation expertise to maintain consistency, compatibility, and shelf stability at scale.

Develop Trend-Driven Skincare Products with Scalable Manufacturing

Moe’s Group supports brands in integrating emerging ingredients into manufacturable skincare formulations. From initial formulation through bulk production, we help ensure consistency, scalability, and alignment with your product strategy.

Request a consultation to discuss ingredient selection, formulation requirements, and production volumes. Our team will outline a clear path from concept to commercial production.